Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Group
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.1976	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.3028	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.4539	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.5219	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.5259	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.5348	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.5426	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.5595	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.5772	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.5800	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6096	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6276	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6336	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6435	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6481	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6594	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6685	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6743	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6744	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6760	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6809	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.6965	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7041	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7074	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7087	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7135	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7150	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7405	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7412	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7432	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7568	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7675	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7721	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7722	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7741	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7797	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.7914	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8043	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8212	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8414	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8487	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8524	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8599	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8636	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8677	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8706	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.8724	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9085	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9105	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9143	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9153	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9177	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9186	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9218	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9264	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9493	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9494	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9498	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9594	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9663	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9719	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9730	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9834	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9950	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	0.9959	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0000	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0046	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0172	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0174	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0176	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0264	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0285	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0288	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0381	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0419	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0510	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0603	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0658	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0797	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.0965	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1006	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1086	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1159	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1227	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1240	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1272	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1366	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1480	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1573	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1615	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1663	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1725	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1727	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1732	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1742	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1764	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.1814	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.2076	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.2381	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.2388	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.2393	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.2564	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.2599	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.2615	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3078	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3161	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3444	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3526	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3562	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3750	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3825	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.3826	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.4140	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.4194	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.4270	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.4292	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.4330	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.4937	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.5257	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.6054	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.6584	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.6787	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.8088	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.8702	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.8937	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	1.9593	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	2.0632	Peak area	Lean
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	2.1300	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	2.1840	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	2.3056	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	oleoyl ethanolamide	2.6007	Peak area	Obese neuropathy